1. Home
  2. NUTX vs XBIT Comparison

NUTX vs XBIT Comparison

Compare NUTX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$209.38

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.16

Market Cap

70.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
XBIT
Founded
2011
2005
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
70.1M
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
NUTX
XBIT
Price
$209.38
$2.16
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$252.50
N/A
AVG Volume (30 Days)
117.6K
43.1K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
N/A
EPS
15.87
N/A
Revenue
$875,257,000.00
N/A
Revenue This Year
$6.12
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
$13.50
N/A
Revenue Growth
82.36
N/A
52 Week Low
$83.99
$2.09
52 Week High
$224.28
$3.44

Technical Indicators

Market Signals
Indicator
NUTX
XBIT
Relative Strength Index (RSI) 65.44 42.52
Support Level $142.71 N/A
Resistance Level N/A $2.46
Average True Range (ATR) 10.19 0.05
MACD 1.29 -0.00
Stochastic Oscillator 72.61 23.53

Price Performance

Historical Comparison
NUTX
XBIT

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: